CSBR - Champions Oncology Inc logo

CSBR

Champions Oncology Inc

Rev —top 1%20Y

Champions Oncology develops technology solutions for drug discovery and development, offering the Tumorgraft platform for personalized cancer care and Lumin Bioinformatics software to support pharmaceutical and biotechnology companies in oncology research.

⚕️ Healthcare NASDAQ Listed 2003 $ USD
$1,000 invested 30 years ago$67,556today

Score Overview

1 Year
Score2.7
Net Growth-147.86%
Net TrendShrank
Net Income Consistency
Rev Growth1.76%
Rev TrendGrew
Revenue Consistency
5 Years
Score3.8
Net Growth-7x
Net Trend40%
Net Income Consistency
Rev Growth41.19%
Rev Trend80%
Revenue Consistency
10 Years
Score5.1
Net Growth78.46%
Net Trend60%
Net Income ConsistencyInconsistent
Rev Growth418.19%
Rev Trend90%
Revenue Consistency89%
20 Years
Score
Net Growth-6x
Net Trend45%
Net Income ConsistencyInconsistent
Rev Growth
Rev Trend89%
Revenue Consistency94%
All Time
Score4.0
Net Growth-14x
Net Trend43%
Net Income ConsistencyInconsistent
Rev Growth27x
Rev Trend80%
Revenue Consistency96%

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-06-25
$ 6.08
1 Year2025-06-25
$ 7.57-19.68%
5 Years2021-06-25
$ 9.54-36.27%
10 Years2016-06-24
$ 2.10189.52%
20 Years2006-06-19
$ 0.03243x
30 Years1996-06-25
$ 0.0967x
All Time2003-01-10
$ 0.01405x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 57M-$ 2M$ 7M
2025$ 56M$ 4M$ 9M
2024$ 50M-$ 7M$ 2M
2023$ 53M-$ 5M$ 10M
2022$ 49M$ 548K$ 9M
2021$ 41M$ 362K$ 4M
2020$ 32M-$ 2M$ 8M
2019$ 27M$ 128K$ 3M
2018$ 20M-$ 1M$ 856K
2017$ 15M-$ 6M$ 3M
2016$ 11M-$ 10M$ 2M
2015$ 8M-$ 13M$ 9M
2014$ 11M-$ 7M$ 5M
2013$ 8M-$ 6M$ 9M
2012$ 7M-$ 8M$ 4M
2011$ 6M-$ 3M$ 10M
2010$ 4M-$ 2M$ 2M
2009$ 3M-$ 2M$ 2M
2008$ 1M-$ 411K$ 3M
2007-$ 170.06K$ 3.76K
2006-$ 303.72K$ 540.00
2005$ 1M-$ 246.54K$ 84.51K
2004$ 1M-$ 107.69K$ 120.12K
IPO2003$ 2M-$ 145.99K$ 195.1K